Literature DB >> 1925286

Rabies in Thailand: 1990.

H Wilde1, S Chutivongse, W Tepsumethanon, P Choomkasien, C Polsuwan, B Lumbertdacha.   

Abstract

Of the more than 100,000 courses of postexposure rabies treatment given in Thailand annually, 95% consist of brain tissue-derived vaccine without immune globulin. Rabies tissue culture vaccines and immune globulins are expensive by the standards of developing countries. When they are given according to either of two proven intradermal postexposure schedules, significant savings can be achieved without loss of efficacy. Purified equine rabies immune globulins account for approximately 10% of the cost of human products administered to exposed individuals and have been shown to be safe and effective. A canine preexposure immunogenicity study with a potent, inactivated tissue culture vaccine revealed that 12.5% of Thai dogs failed to develop protective antibody titers 2 months after one subcutaneous injection. Previous studies have shown significant antigenic differences between Thai street rabies virus and European and North African strains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1925286     DOI: 10.1093/clinids/13.4.644

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  9 in total

1.  Epidemiologic trends of rabies in domestic animals in southern Thailand, 1994-2008.

Authors:  Anyarat Thiptara; Edward R Atwill; Wandee Kongkaew; Bruno B Chomel
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Intravitam diagnosis of human rabies by PCR using saliva and cerebrospinal fluid.

Authors:  P Crepin; L Audry; Y Rotivel; A Gacoin; C Caroff; H Bourhy
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 3.  Rabies in China: recommendations for control.

Authors:  A Kureishi; L Z Xu; H Wu; H G Stiver
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

4.  Acute flaccid paralysis due to rabies.

Authors:  J B Ghosh; Mahua Roy; Kalyan Lahiri; A K Bala; Mahua Roy
Journal:  J Pediatr Neurosci       Date:  2009-01

5.  Immunogenicity of Simulated PCECV Postexposure Booster Doses 1, 3, and 5 Years after 2-Dose and 3-Dose Primary Rabies Vaccination in Schoolchildren.

Authors:  Thavatchai Kamoltham; Wiravan Thinyounyong; Pakamatz Khawplod; Phran Phraisuwan; Phana Phongchamnaphai; Gerlind Anders; Claudius Malerczyk
Journal:  Adv Prev Med       Date:  2011-07-07

6.  Achieving population-level immunity to rabies in free-roaming dogs in Africa and Asia.

Authors:  Michelle K Morters; Trevelyan J McKinley; Daniel L Horton; Sarah Cleaveland; Johan P Schoeman; Olivier Restif; Helen R Whay; Amelia Goddard; Anthony R Fooks; I Made Damriyasa; James L N Wood
Journal:  PLoS Negl Trop Dis       Date:  2014-11-13

7.  Paralytic rabies following cat scratch and intra-dermal anti-rabies vaccination.

Authors:  Vykuntaraju K Gowda; G V Basavaraja; Hamsa Reddy; Premalatha Ramaswamy
Journal:  J Pediatr Neurosci       Date:  2014-05

Review 8.  Potential Pathogens Reported in Species of the Family Viverridae and Their Implications for Human and Animal Health.

Authors:  L V Wicker; P J Canfield; D P Higgins
Journal:  Zoonoses Public Health       Date:  2016-06-30       Impact factor: 2.702

9.  Knowledge, attitude and practice about rabies among children receiving formal and informal education in Samaru, Zaria, Nigeria.

Authors:  Asabe Adamu Dzikwi; Ayuba Sini Ibrahim; Jarlath Udoudo Umoh
Journal:  Glob J Health Sci       Date:  2012-08-09
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.